Recanalisation of cerebral venous thrombosis

被引:100
作者
Baumgartner, RW
Studer, A
Arnold, M
Georgiadis, D
机构
[1] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland
[2] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland
关键词
D O I
10.1136/jnnp.74.4.459
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate recanalisation in the first 12 months after cerebral venous thrombosis. Methods: 33 consecutive patients presenting with cerebral venous thrombosis were enrolled in the study. Diagnosis was made by magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) or catheter angiography. Patients were initially treated with intravenous heparin. Warfarin was given for at least four months. Cerebral MRI and MRV were done at four months and repeated after 12 months if venous thrombosis persisted. Outcome was evaluated by the Rankin scale at 12 months. Results: Outcome at 12 months was good, with a median modified Rankin scale score of 0 (range 0 to 2); 27 patients (82%) had no residual deficits. No patient suffered recurrent cerebral venous thrombosis, deep vein thrombosis, or pulmonary embolism during follow up. After four months, all deep cerebral veins and cavernous sinuses, 94% of superior sagittal sinuses, 80% of straight sinuses, 73% of jugular veins, 58% of transverse sinuses, and 41% of sigmoid sinuses had recanalised. No further recanalisation was observed thereafter. Conclusions: The results suggest that recanalisation only occurs within the first four months following cerebral venous thrombosis and not thereafter, irrespective of oral anticoagulation.
引用
收藏
页码:459 / 461
页数:3
相关论文
共 12 条
[1]  
Charbonnier BA, 1998, THROMB HAEMOSTASIS, V79, P897
[2]   Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis [J].
de Bruijn, SFTM ;
Stam, J .
STROKE, 1999, 30 (03) :484-488
[3]   HEPARIN TREATMENT IN SINUS VENOUS THROMBOSIS [J].
EINHAUPL, KM ;
VILLRINGER, A ;
MEISTER, W ;
MEHRAEIN, S ;
GARNER, C ;
PELLKOFER, M ;
HABERL, RL ;
PFISTER, HW ;
SCHMIEDEK, P .
LANCET, 1991, 338 (8767) :597-600
[4]   Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home [J].
Koopman, MMW ;
Prandoni, P ;
Piovella, F ;
Ockelford, PA ;
Brandjes, DPM ;
vanderMeer, J ;
Gallus, AS ;
Simonneau, G ;
Chesterman, CH ;
Prins, MH ;
Bossuyt, PMM ;
deHaes, H ;
vandenBelt, AGM ;
Sagnard, L ;
DAzemar, P ;
Buller, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :682-687
[5]   FLOW QUANTIFICATION IN THE SUPERIOR SAGITTAL SINUS USING MAGNETIC-RESONANCE [J].
MATTLE, H ;
EDELMAN, RR ;
REIS, MA ;
ATKINSON, DJ .
NEUROLOGY, 1990, 40 (05) :813-815
[6]   CEREBRAL VENOGRAPHY WITH MR [J].
MATTLE, HP ;
WENTZ, KU ;
EDELMAN, RR ;
WALLNER, B ;
FINN, JP ;
BARNES, P ;
ATKINSON, DJ ;
KLEEFIELD, J ;
HOOGEWOUD, HM .
RADIOLOGY, 1991, 178 (02) :453-458
[7]   Long-term prognosis in cerebral venous thrombosis - Follow-up of 77 patients [J].
Preter, M ;
Tzourio, C ;
Ameri, A ;
Bousser, MG .
STROKE, 1996, 27 (02) :243-246
[8]  
SACHS L, 1978, ANGEWANDTE STAT, P278
[9]   A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM [J].
SCHULMAN, S ;
RHEDIN, AS ;
LINDMARKER, P ;
CARLSSON, A ;
LARFARS, G ;
NICOL, P ;
LOOGNA, E ;
SVENSSON, E ;
LJUNGBERG, B ;
WALTER, H ;
VIERING, S ;
NORDLANDER, S ;
LEIJD, B ;
JONSSON, KA ;
HJORTH, M ;
LINDER, O ;
BOBERG, J ;
GUSTAFSSON, C ;
GRONDAHL, A ;
TORNEBOHM, E ;
JOHANSSON, M ;
LOCKNER, D ;
JOHNSSON, H ;
KOBOSKO, J ;
MALMROS, B ;
ARCINI, N ;
SAAW, J ;
STIG, R ;
WILHELMSSON, S ;
OHLSSON, A ;
MALMQVIST, K ;
ALKHALILI, F ;
PETRESCU, A ;
BROHULT, J ;
HULTING, J ;
EKLUND, SG ;
DAHLIN, L ;
MARJANOVICS, B ;
MALM, C ;
LINDGREN, A ;
FAGRELL, B ;
KALLNER, M ;
GRANQVIST, S ;
WIMAN, B ;
EGBERG, N ;
WADMAN, B ;
SNYDER, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (25) :1661-1665
[10]  
SUDLOW MF, 1992, LANCET, V340, P873